ACTIVE

PHARMA TECHNOLOGY

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

3,8 M €

-13.0% YoY

Revenue

26,8 M €

+1.2% YoY

Equity

16,3 M €

+13.6% YoY

Workforce

69,9 ETP

+5.7% YoY

What does PHARMA TECHNOLOGY do?

PHARMA TECHNOLOGY is a Public limited company incorporated in 1991. Its registered office is in Nivelles. It employs on average 69,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0443.803.803

Incorporation

29/03/1991

Legal form

Public limited company

Registered office

Rue Graham Bell 8
1402 Nivelles · WallonieSee on map

Contributed capital

61 973,38 €

Latest accounts

31/12/2025

Average workforce

69,9 ETP

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2013		2012		2011		2010		2009		2008		2007
Income statement
Revenue	26,8 M €	+1.2%	26,5 M €	+7.7%	24,6 M €	+25.2%	19,6 M €	+1.2%	19,4 M €	+26.3%	15,4 M €	-9.0%	16,9 M €	+5.4%	16 M €	+14.7%	13,9 M €	-11.8%	15,8 M €	+28.9%	12,3 M €	+28.0%	9,6 M €	+23.0%	7,8 M €	-19.8%	9,7 M €		–		–		–		–		–		–
EBITDA	5,7 M €	-6.8%	6,1 M €	+7.8%	5,6 M €	+43.5%	3,9 M €	-14.4%	4,6 M €	+41.7%	3,2 M €	-25.2%	4,3 M €	+9.2%	4 M €	+78.7%	2,2 M €	-38.5%	3,6 M €	+46.5%	2,5 M €	+60.1%	1,5 M €	+12.0%	1,4 M €	-31.6%	2 M €	+135%	857,8 k €	+5.3%	814,6 k €	+4.3%	781,3 k €	+29.9%	601,3 k €	-64.9%	1,7 M €	-21.4%	2,2 M €
Operating result	4,2 M €	-4.6%	4,4 M €	+7.6%	4,1 M €	+38.4%	3 M €	-22.3%	3,8 M €	+71.7%	2,2 M €	-33.0%	3,3 M €	+7.9%	3,1 M €	+83.5%	1,7 M €	-47.8%	3,2 M €	+52.9%	2,1 M €	+76.6%	1,2 M €	+5.2%	1,1 M €	-18.3%	1,4 M €	+176%	501 k €	+10.5%	453,4 k €	+3.9%	436,2 k €	+71.9%	253,7 k €	-82.2%	1,4 M €	-26.0%	1,9 M €
Net result	3,8 M €	-13.0%	4,3 M €	+10.3%	3,9 M €	+30.1%	3 M €	-19.1%	3,7 M €	+70.4%	2,2 M €	-33.4%	3,3 M €	+18.3%	2,8 M €	+94.1%	1,4 M €	-45.9%	2,7 M €	+35.5%	2 M €	+57.2%	1,2 M €	+9.6%	1,1 M €	-17.7%	1,4 M €	+291%	352,9 k €	+81.8%	194,1 k €	-31.6%	283,7 k €	+70.2%	166,6 k €	-82.1%	930,8 k €	-23.2%	1,2 M €
Balance sheet
Equity	16,3 M €	+13.6%	14,3 M €	+3.9%	13,8 M €	-14.2%	16,1 M €	-11.2%	18,1 M €	+0.7%	18 M €	-2.0%	18,3 M €	+8.3%	16,9 M €	+22.6%	13,8 M €	+11.6%	12,4 M €	+27.1%	9,7 M €	+24.6%	7,8 M €	+18.3%	6,6 M €	+20.2%	5,5 M €	+32.4%	4,2 M €	+13.5%	3,7 M €	+5.5%	3,5 M €	+8.2%	3,2 M €	+4.8%	3,1 M €	-12.2%	3,5 M €
Total assets	23,9 M €	+1.6%	23,5 M €	-8.4%	25,7 M €	-1.3%	26 M €	-0.2%	26,1 M €	+5.1%	24,8 M €	-6.3%	26,5 M €	+13.0%	23,4 M €	+10.9%	21,1 M €	+30.9%	16,2 M €	+28.5%	12,6 M €	+23.9%	10,2 M €	+10.6%	9,2 M €	+12.9%	8,1 M €	+15.9%	7 M €	+21.7%	5,8 M €	+1.4%	5,7 M €	+10.2%	5,2 M €	+6.4%	4,8 M €	-9.7%	5,4 M €
Cash	2,1 M €	-60.7%	5,4 M €	+114%	2,5 M €	-12.2%	2,9 M €	-56.3%	6,6 M €	-1.8%	6,7 M €	-34.8%	10,3 M €	+61.7%	6,4 M €	+32.9%	4,8 M €	+9.4%	4,4 M €	+28.4%	3,4 M €	+60.6%	2,1 M €	+15.6%	1,8 M €	+22.7%	1,5 M €	-23.8%	2 M €	+98.6%	990,6 k €	-39.5%	1,6 M €	+56.9%	1 M €	+46.6%	711,9 k €	-40.9%	1,2 M €
Debts	7,4 M €	-16.3%	8,8 M €	-24.2%	11,7 M €	+22.2%	9,5 M €	+25.7%	7,6 M €	+16.1%	6,5 M €	-16.5%	7,8 M €	+31.5%	5,9 M €	-16.6%	7,1 M €	+93.7%	3,7 M €	+39.0%	2,7 M €	+14.8%	2,3 M €	-8.1%	2,5 M €	-1.8%	2,6 M €	-4.5%	2,7 M €	+35.8%	2 M €	-7.8%	2,1 M €	+17.0%	1,8 M €	+11.3%	1,6 M €	-3.9%	1,7 M €
Other
Workforce	69,9 ETP	+5.7%	66,1 ETP	-1.5%	67,1 ETP	+11.6%	60,1 ETP	-2.1%	61,4 ETP	-0.8%	61,9 ETP	+12.3%	55,1 ETP	+9.5%	50,3 ETP	+5.7%	47,6 ETP	+15.5%	41,2 ETP	+11.1%	37,1 ETP	+16.3%	31,9 ETP	-1.5%	32,4 ETP	+10.2%	29,4 ETP	+12.2%	26,2 ETP	+19.1%	22,0 ETP	+2.8%	21,4 ETP	-6.6%	22,9 ETP	0.0%	22,9 ETP	+43.1%	16,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

Claire Becker

Director · since 30 juin 2022 · until 08 juin 2028

Active

PHARMA FLEX

Managing director · since 30 juin 2022 · until 08 juin 2028 · 0897.187.147

Represented by Dollinger Martial

Active

Ended mandates

PHARMA FLEX

Managing director · since 30 juin 2022 · until 08 juin 2028 · 0897.187.147

Represented by Dollinger Martial

Ended

Claire BECKER

Director · since 01 avril 2016 · until 09 juin 2022

Ended

PHARMA FLEX

Managing director · since 01 avril 2016 · until 09 juin 2022 · 0897.187.147

Represented by Martial DOLLINGER

Ended

Claire BECKER

Director · since 01 avril 2010 · until 01 avril 2016

Ended

At this address

Other companies at this address

Company	CBE no.
AdFinitis● Active	1012.280.815
DOLFINANCE● Active	0444.022.844
DOLLIMMO BELGIUM● Active	0765.300.009
NextGen Invest● Active	1004.718.674
PHARMA FLEX● Active	0897.187.147
PHARMA VAT UNIT● Active	0654.817.207

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/03/2026	15/04/2025	19/06/2024	24/10/2023	27/07/2022	28/07/2021
General meeting	26/03/2026	26/03/2025	13/06/2024	08/06/2023	30/06/2022	24/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	26/03/2026	27/03/2026	French	PDF
Full model	31/12/2024	26/03/2025	15/04/2025	French	PDF
Full model	31/12/2023	13/06/2024	19/06/2024	French	PDF
Full modelCorrection	31/12/2022	08/06/2023	24/10/2023	French	PDF
Full model	31/12/2022	08/06/2023	07/07/2023	French	PDF
Full model	31/12/2021	30/06/2022	27/07/2022	French	PDF
Full model	31/12/2020	24/06/2021	28/07/2021	French	PDF
Full model	31/12/2019	29/06/2020	10/07/2020	French	PDF
Full model	31/12/2018	13/06/2019	30/07/2019	French	PDF
Full model	31/12/2017	14/06/2018	24/07/2018	French	PDF
Full model	31/12/2016	08/06/2017	26/07/2017	French	PDF
Full model	31/12/2015	09/06/2016	08/07/2016	French	PDF
Full model	31/12/2014	11/06/2015	29/07/2015	French	PDF
Full model	31/12/2013	12/06/2014	01/07/2014	French	PDF
Full model	31/03/2013	20/09/2013	31/10/2013	French	PDF
Abridged model	31/03/2012	21/09/2012	28/11/2012	French	PDF
Abridged model	31/03/2011	16/09/2011	21/10/2011	French	PDF
Abridged model	31/03/2010	17/09/2010	22/11/2010	French	PDF
Abridged model	31/03/2009	18/09/2009	16/11/2009	French	PDF
Abridged model	31/03/2008	19/09/2008	25/11/2008	French	PDF
Abridged model	31/03/2007	21/09/2007	23/10/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

Claire Becker

Director · since 30 juin 2022 · until 08 juin 2028

Active

PHARMA FLEX

Managing director · since 30 juin 2022 · until 08 juin 2028 · 0897.187.147

Represented by Dollinger Martial

Active

Ended mandates

PHARMA FLEX

Managing director · since 30 juin 2022 · until 08 juin 2028 · 0897.187.147

Represented by Dollinger Martial

Ended

Claire BECKER

Director · since 01 avril 2016 · until 09 juin 2022

Ended

PHARMA FLEX

Managing director · since 01 avril 2016 · until 09 juin 2022 · 0897.187.147

Represented by Martial DOLLINGER

Ended

Claire BECKER

Director · since 01 avril 2010 · until 01 avril 2016

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/01/2025
DEMISSIONS, NOMINATIONS
PDF
Other25/01/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates08/11/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates03/10/2019
DEMISSIONS, NOMINATIONS
PDF
Registered office30/11/2017
SIEGE SOCIAL
PDF
Mandates05/09/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates18/04/2016
DEMISSIONS, NOMINATIONS
PDF
Registered office06/10/2014
SIEGE SOCIAL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20253,8 M €↓
2024
Annual accounts 20244,3 M €↑
2023
Annual accounts 20233,9 M €↑
2022
Annual accounts 20223 M €↓
2021
Annual accounts 20213,7 M €↑
2020
Annual accounts 20202,2 M €↓
2019
Annual accounts 20193,3 M €↑
2018
Annual accounts 20182,8 M €↑
2017
Annual accounts 20171,4 M €↓
2016
Annual accounts 20162,7 M €↑
2015
Annual accounts 20152 M €↑
2014
Annual accounts 20141,2 M €↑
2013
Annual accounts 20131,1 M €↓
2013
Annual accounts 20131,4 M €↑
2012
Annual accounts 2012352,9 k €↑
2011
Annual accounts 2011194,1 k €↓
2010
Annual accounts 2010283,7 k €↑
2009
Annual accounts 2009166,6 k €↓
2008
Annual accounts 2008930,8 k €↓
2007
Annual accounts 20071,2 M €
29/03/1991
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA TECHNOLOGY

Overview

What does PHARMA TECHNOLOGY do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline